SRSigurdur Ragnarsson

Sigurdur Ragnarsson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sigurdur Ragnarsson has a total of 190 co-authors. Here are the top co-authors by number of shared publications:

  • Shahab Nozohoor

    Department of Cardiothoracic Surgery, Skåne University Hospital, Lund University, Lund, Sweden

    10 shared publications
  • Johan Sjögren

    Department of Clinical Sciences, Lund University, Lund, Sweden

    9 shared publications
  • Antonio Fiore

    Cardiac Surgery Unit, Hôpital “Henri Mondor—Assistance Publique Hôpîtaux de Paris”, 94100 Créteil, France

    6 shared publications
  • Anders Jeppsson

    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg

    5 shared publications
  • Andrea Lechiancole

    Cardiothoracic Department, University Hospital of Udine, Udine, Italy

    5 shared publications
  • Andrea Perrotti

    Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France

    5 shared publications

Latest Publications

  • Open Access

    Mid-term follow-up of non-ischemic heart preservation in heart transplantation

    by Victoria Jernryd, Oscar Braun, Audrius Paskevicius, Carsten Metzsch, Ida Haugen Lofman, Sigurdur Ragnarsson, Joanna-Maria Papageorgiou, Annika Ingvarsson, Stig Steen, Johan Nilsson


  • Open Access

    Non–β-hemolytic Streptococcal Bacteremia in Patients With Heart Valve Prosthesis—Is It Always Infective Endocarditis?

    by Fanni Toivonen, Torgny Sunnerhagen, Johannes Lundin, Anna Bläckberg, Sigurdur Ragnarsson, Magnus Rasmussen

    Background: Non–β-hemolytic streptococci are among the most common causative agents of infective endocarditis (IE). Patients with a heart valve prosthesis (HVP) have a high risk of IE. We aimed to determine the risk for IE in patients with HVP and non–β-hemolytic streptococcal bacteremia (NBHSB) and to study NBHSB relapse depending on treatment duration. Method: Adults with HVP and NBHSB from 2015 to 2018 in the region of Skåne, Sweden, were identified through the Clinical Microbiology Laboratory in Lund and evaluated in a population-based investigation. Data were collected from medical records according to a predefined protocol. Results: A total of 110 NBHSB episodes in 89 patients with HVP were included. In 40 episodes (36%), the patients had definite IE, in 69 possible IE, and 1 had rejected IE according to the European Society of Cardiology 2015 criteria. Of the 70 patients without a definite diagnosis of IE, 28 (40%) were treated with antibiotics as if they had IE. There were 7 NBHSB relapses, and 6 of these occurred in patients with possible IE. Four relapses occurred in patients who received antibiotics for <14 days. Three patients with possible IE were diagnosed with definite IE at the time of the relapse. Conclusions: Patients with NBHSB and HVP have a high risk for IE and should be thoroughly investigated. Most patients with NBHSB and HVP who fulfilled criteria for possible IE did not receive long-course antibiotic treatment. Moreover, some patients treated with a short course of antibiotics experienced NBHSB relapse.

  • Open Access

    Pacemaker implantation after cardiac surgery: a contemporary, nationwide perspective

    by Amar Taha, Alice David, Sigurdur Ragnarsson, Piotr Szamlewski, Shabbar Jamaly, J. Gustav Smith, Susanne J. Nielsen, Anders Jeppsson, Andreas Martinsson

    Background Cardiac surgery entails an increased risk for brady-arrhythmias. Currently known rates for permanent pacemaker (PPM) implantation after cardiac surgery are derived from non-contemporary studies. This study aimed to explore the incidence and indications for PPM implantation at 30 days and one year after different cardiac surgical procedures in a modern cohort. Methods All first-time coronary artery bypass grafting (CABG) and/or valvular surgery patients in Sweden 2006 - 2020 without previous PPM or implantable cardioverter-defibrillator (ICD) (n= 76,447) were included in this nationwide population-based study using data from four national registries. Patients undergoing heart transplantation and those who subsequently received an ICD were excluded. Results A PPM was implanted in 8.2% (n= 6,271) of the patients, 35% (n= 2,196) within the first 30 days and 46.3% (n= 2,647) at one year following surgery. The main indication of PPM implantation was atrioventricular block. Tricuspid valve surgery exhibited the highest cumulative incidence for PPM both at 30 days (6.8% (95% confidence interval 4.3 – 10.0)) and one year (8.8% (95% CI 6.0 – 12.0)) surpassing mitral valve surgery (30-day 5.3% (95% CI 4.7-6.0); one-year 6.5% (95% CI 5.8-7.3)), aortic valve surgery (30-day 4.8% (95% CI 4.5-5.1); one-year 6.0% (95% CI 5.6-6.3)) and CABG (30-day 0.74% (95% CI 0.66-0.83); one-year 1.3% (95% CI 1.2-1.35)). The incidence following combined operations (multiple valves and/or coronary surgery) was 6.5% (95% CI 6.0 – 6.9) and 8.1% (95% CI 7.7 – 8.6) at 30 days and one year respectively. Concomitant ablation surgery increased the risk even further (adjusted Hazard Ratio 9.20 (95% CI 7.96-10.64), pConclusions The need for PPM after cardiac surgery is common, primarily due to atrioventricular block. Tricuspid valve surgery is associated with the highest risk for PPM implantation amongst isolated procedures. Combined procedures and concomitant surgical ablation further increase that risk. What is new? Permanent pacemaker after cardiac surgery is not uncommon with atrioventricular blocking being the main indication. Tricuspid valve surgery had the highest cumulative incidence at 30 days and one year, exceeding other isolated procedures. Combined cardiac surgical procedures and concomitant ablation surgery increased the risk even further. What are the clinical implications? This information is valuable while informing individual patients awaiting cardiac surgery about potential post-operative complications. Recognizing patients at higher risk enables targeted postoperative care, including closer monitoring for signs of conduction disturbances. Studies investigating and identifying predictors of post-cardiac surgery bradyarrhythmias and subsequent need for permanent pacemakers are needed.


  • Open Access

    Pacemaker implantation following tricuspid valve annuloplasty

    by Sigurdur Ragnarsson, Amar Taha, Susanne J. Nielsen, Andrea Amabile, Arnar Geirsson, Markus Krane, David Mörtsell, Johan Sjögren, Anders Jeppsson, Andreas Martinsson


  • Open Access

    Central versus Peripheral Postcardiotomy Veno-Arterial Extracorporeal Membrane Oxygenation: Systematic Review and Individual Patient Data Meta-Analysis

    by Fausto Biancari, Alexander Kaserer, Andrea Perrotti, Vito G. Ruggieri, Sung-Min Cho, Jin Kook Kang, Magnus Dalén, Henryk Welp, Kristján Jónsson, Sigurdur Ragnarsson, et al.

    Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle. Results: The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08–1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, p = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04–1.76, I2 21%). Conclusions: Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO.


  • Open Access

    Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality—a nationwide study

    by Andreas Dalsgaard Jensen, Lauge Østergaard, Jeppe K. Petersen, Peter Graversen, Jawad H. Butt, Henning Bundgaard, Claus Moser, Morten H. Smerup, Ivy S. Modrau, Kasper Iversen, et al.

    Background: Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of valve surgery do not exist. Methods: We included patients with first-time IE (1999–2018) using Danish nationwide registries. Proportions of valve surgery were reported for calendar periods (1999–2003, 2004–2008, 2009–2013, 2014–2018). Comparing calendar periods in multivariable analyses, we computed likelihoods of valve surgery with logistic regression and rates of 30 day postoperative mortality with Cox regression. Results: We included 8804 patients with first-time IE; 1981 (22.5%) underwent surgery during admission, decreasing by calendar periods (N = 360 [24.4%], N = 483 [24.0%], N = 553 [23.5%], N = 585 [19.7%], P = < 0.001 for trend). For patients undergoing valve surgery, median age increased from 59.7 to 66.9 years (P ≤ 0.001) and the proportion of males increased from 67.8% to 72.6% (P = 0.008) from 1999–2003 to 2014–2018. Compared with 1999–2003, associated likelihoods of valve surgery were: Odds ratio (OR) = 1.14 (95% CI: 0.96–1.35), OR = 1.20 (95% CI: 1.02–1.42), and OR = 1.10 (95% CI: 0.93–1.29) in 2004–2008, 2009–2013, and 2014–2018, respectively. 30 day postoperative mortalities were: 12.7%, 12.8%, 6.9%, and 9.7% by calendar periods. Compared with 1999–2003, associated mortality rates were: Hazard ratio (HR) = 0.96 (95% CI: 0.65–1.41), HR = 0.43 (95% CI: 0.28–0.67), and HR = 0.55 (95% CI 0.37–0.83) in 2004–2008, 2009–2013, and 2014–2018, respectively. Conclusions: On a nationwide scale, 22.5% of patients with IE underwent valve surgery. Patient characteristics changed considerably and use of valve surgery decreased over time. The adjusted likelihood of valve surgery was similar between calendar periods with a trend towards an increase while rates of 30 day postoperative mortality decreased.


  • Open Access

    Microbiological etiology in prosthetic valve endocarditis: A nationwide registry study

    by Blerand Berisha, Sigurdur Ragnarsson, Lars Olaison, Magnus Rasmussen

    Background: Prosthetic valve endocarditis (PVE) is a feared complication after heart valve surgery. Studies on differences in bacteriology in various types of PVE are limited.Objectives: This study aimed to investigate the microbiology of PVE depending on the type of prosthetic valve and timing of diagnosis.Methods: A retrospective study based on the Swedish Registry on Infective Endocarditis focusing on PVE was conducted. The cohort was divided into mechanical and bioprosthetic valves; into endocarditis localization in the aortic, mitral, or tricuspid valve; and into early and late PVE. The microbiology in these groups was compared. Predictors of Staphylococcus aureus as the cause of PVE were examined by multivariable logistic regression.Results: A total of 780 episodes of PVE in 749 patients were compared regarding the distribution of causative microbiological agents. The most common agents included alpha‐hemolytic streptococci (29%), S. aureus (22%), enterococci (14%), coagulase‐negative staphylococci (CoNS) (12%), and Cutibacterium acnes (6%). S. aureus was more commonly found on mechanical valves compared to bioprosthetic ones (36% vs. 17%, p < 0.001) whereas alpha‐hemolytic streptococci, enterococci, and CoNS were more common on bioprosthetic valves. There were no significant differences in the microbiology of PVE affecting mitral or aortic valves or in cases of early and late PVE. Predictors for S. aureus as the cause of PVE were end‐stage renal disease, intravenous drug use, mechanical valve, and tricuspid localization of endocarditis.Conclusions: The type of prosthetic heart valve is associated with the causative pathogen. Patients with mechanical valves are more likely to have PVE caused by S. aureus.


  • Open Access

    Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation With and Without Intra-Aortic Balloon Pump

    by Björk Björnsdóttir, Fausto Biancari, Magnus Dalén, Angelo M. Dell'AQuila, Kristján Jónsson, Antonio Fiore, Giovanni Mariscalco, Zein El-Dean, Giuseppe Gatti, Svante Zipfel, et al.


  • Open Access

    Surgery Is Underused in Elderly Patients With Left‐Sided Infective Endocarditis: A Nationwide Registry Study

    by Sigurdur Ragnarsson, Sonsoles Salto‐Alejandre, Axel Ström, Lars Olaison, Magnus Rasmussen

    Background: Infective endocarditis is associated with higher mortality in elderly patients, but the role of surgery in this group has not been fully evaluated. The aim of this study was to assess outcomes of left‐sided infective endocarditis in elderly patients and to determine the influence of surgery on mortality in the elderly. Methods and Results: A nationwide retrospective study was performed of 2186 patients with left‐sided infective endocarditis recorded in the SRIE (Swedish Registry of Infective Endocarditis), divided into patients aged P <0.001]). Conclusions: The proportion of elderly patients with infective endocarditis who underwent surgery was low compared with that of younger patients. Surgery was associated with lower mortality irrespective of age. In matched elderly patients, long‐term mortality was higher in patients who did not undergo surgery, suggesting that surgery is underused in elderly patients.


  • Neurologic Injury in Patients Treated With Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock

    by Fanni Toivonen, Fausto Biancari, Magnus Dalén, Angelo M. Dell'AQuila, Kristján Jónsson, Antonio Fiore, Giovanni Mariscalco, Zein El-Dean, Giuseppe Gatti, Svante Zipfel, et al.